BioCentury | Feb 28, 2017
Clinical News

Merck CMV prophylaxis headed for U.S., EU submissions

...of development of clinically significant CMV infection compared to placebo in 495 adults without detectable CMV DNA...
BioCentury | Feb 29, 2016
Clinical News

Brincidofovir: Additional Phase III data

...in the placebo arm. Brincidofovir also missed the secondary endpoints of preventing infection with non- CMV DNA...
BioCentury | Mar 2, 2015
Clinical News

Maribavir: Additional Phase II data

...infection showed that twice-daily 400, 800 and 1,200 mg oral maribavir led to undetectable plasma CMV DNA...
BioCentury | May 6, 2013
Clinical News

Maribavir: Interim Phase II data

...in a U.S. Phase II trial showed that twice-daily oral maribavir led to undetectable plasma CMV DNA...
BioCentury | May 6, 2013
Clinical News

Maribavir: Interim Phase II data

...in a European Phase II trial showed that twice-daily oral maribavir led to undetectable plasma CMV DNA...
...cytomegalovirus (CMV) infection in hematopoietic stem cell or solid organ transplant recipients Endpoint: Safety; plasma CMV DNA...
BioCentury | Sep 24, 2012
Company News

Roche sales and marketing update

...patients who are undergoing anti-cytomegalovirus (CMV) therapy. The in vitro nucleic acid amplification test quantifies CMV DNA...
BioCentury | Jul 16, 2012
Clinical News

Cobas AmpliPrep/Cobas TaqMan CMV Test regulatory update

...the test in the U.S. next month. The in vitro nucleic acid amplification test quantifies CMV DNA...
BioCentury | Jun 11, 2012
Clinical News

Maribavir: Phase II started

...cytomegalovirus (CMV) infection in hematopoietic stem cell or solid organ transplant patients Endpoint: Safety; plasma CMV DNA...
BioCentury | Apr 11, 2011
Clinical News

Cobas AmpliPrep/Cobas TaqMan CMV Test regulatory update

...the product is already available in Europe. The in vitro nucleic acid amplification test quantifies CMV DNA...
BioCentury | Mar 15, 2010
Clinical News

CMX001: Phase II started

...infection in stem cell transplant recipients Endpoint: Safety and emergence or progression of CMV infection; CMV DNA...
Items per page:
1 - 10 of 32